About Azienda Ospedaliera Le Molintte di Torino; Dipartimento Di Neurologia - Oncologia
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Azienda Ospedaliera Le Molintte di Torino; Dipartimento Di Neurologia - Oncologia
During the past decade, Azienda Ospedaliera Le Molintte di Torino; Dipartimento Di Neurologia - Oncologia conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Once a Day (QD) - Twice a Day (BID) Clinical Trial: Didanosine, Lamivudine and Efavirenz Versus Zidovudine, Lamivudine and Efavirenz in the Starting Treatment of HIV
OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer
Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression
2010-03-01
2012-06-01
Completed
525
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Azienda Ospedaliera Le Molintte di Torino; Dipartimento Di Neurologia - Oncologia
According to Clinical.Site data, the most researched conditions in "Azienda Ospedaliera Le Molintte di Torino; Dipartimento Di Neurologia - Oncologia" are
"Glioblastoma" (2 trials), "Chronic Cluster Headache" (1 trials), "Cluster Headache, Episodic" (1 trials), "Multiple Sclerosis" (1 trials) and "Neoplasms" (1 trials). Many other conditions were trialed in "Azienda Ospedaliera Le Molintte di Torino; Dipartimento Di Neurologia - Oncologia" in a lesser frequency.
Clinical Trials Intervention Types at Azienda Ospedaliera Le Molintte di Torino; Dipartimento Di Neurologia - Oncologia
Most popular intervention types in "Azienda Ospedaliera Le Molintte di Torino; Dipartimento Di Neurologia - Oncologia" are "Drug" (7 trials) and "Radiation" (2 trials). Other intervention types were less common.
The name of intervention was led by "Bevacizumab" (3 trials), "Placebo" (3 trials), "Eptinezumab" (2 trials), "Ocrelizumab" (2 trials) and "Temozolomide" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Azienda Ospedaliera Le Molintte di Torino; Dipartimento Di Neurologia - Oncologia
The vast majority of trials in "Azienda Ospedaliera Le Molintte di Torino; Dipartimento Di Neurologia - Oncologia" are
7 trials for "All" genders.
Clinical Trials Status at Azienda Ospedaliera Le Molintte di Torino; Dipartimento Di Neurologia - Oncologia
Currently, there are NaN active trials in "Azienda Ospedaliera Le Molintte di Torino; Dipartimento Di Neurologia - Oncologia".
undefined are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Azienda Ospedaliera Le Molintte di Torino; Dipartimento Di Neurologia - Oncologia,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Azienda Ospedaliera Le Molintte di Torino; Dipartimento Di Neurologia - Oncologia, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".